Pathstone Holdings’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.73M Sell
273,446
-32,021
-10% -$740K 0.02% 536
2026
Q1
$7.31M Sell
305,467
-16,081
-5% -$393K 0.03% 440
2025
Q4
$7.28M Sell
321,548
-44,709
-12% -$973K 0.03% 429
2025
Q3
$7.38M Sell
366,257
-42,244
-10% -$708K 0.03% 437
2025
Q2
$5.83M Buy
408,501
+31,098
+8% +$363K 0.02% 494
2025
Q1
$3.97M Sell
377,403
-171,326
-31% -$1.94M 0.02% 640
2024
Q4
$6.65M Buy
548,729
+1,936
+0.4% +$25.3K 0.03% 449
2024
Q3
$8.03M Buy
546,793
+3,698
+0.7% +$51.5K 0.04% 397
2024
Q2
$7.84M Sell
543,095
-19,135
-3% -$306K 0.04% 383
2024
Q1
$9.15M Buy
562,230
+459,781
+449% +$7.19M 0.04% 320
2023
Q4
$1.53M Buy
+102,449
New +$1.16M 0.01% 844

Other funds holding ELAN

Pathstone Holdings's ELAN Position: Q2 2026 in Review

Pathstone Holdings reduced its Elanco Animal Health (ELAN) stake by 10% in Q2 2026, selling an estimated $740K and leaving 273,446 shares worth $6.73M. The position accounts for 0.02% of the portfolio, ranked #536.

Pathstone Holdings first reported a position in ELAN in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.15M in Q1 2024. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Pathstone Holdings held 273,446 shares of Elanco Animal Health worth $6.73M as of Q2 2026.
  • Pathstone Holdings sold 32,021 Elanco Animal Health shares in Q2 2026, an estimated $740K.
  • Elanco Animal Health made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #536 holding.
  • Pathstone Holdings first reported a position in Elanco Animal Health in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Elanco Animal Health position peaked at $9.15M in Q1 2024.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.